Digoxin ToxicityEvaluation in Clinical Practice with Pharmacokinetic Correlations

被引：0
作者：
Karine Lecointre
Laurence Pisanté
Francis Fauvelle
Serge Mazouz
机构：
[1] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service Pharmacie
[2] Centre Hospitalier Intercommunal Le Raincy-Montfermeil,Service de Cardiologie
来源：
Clinical Drug Investigation | 2001年 / 21卷
关键词：
Root Mean Square Error; Digoxin; Total Clearance; Digoxin Concentration; Serum Digoxin Concentration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 232
页数：7
相关论文
共 50 条
[21]   Population Pharmacokinetic Investigation of Digoxin in Japanese Infants and Young Children [J].
Yukawa, Miho ;
Yukawa, Eiji ;
Suematsu, Fumihiro ;
Takiguchi, Takako ;
Ikeda, Hirohito ;
Aki, Hatsumi ;
Mimemoto, Masao .
JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06) :857-863
[22]   Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin [J].
Snel, S ;
Jansen, JA ;
Pedersen, PC ;
Jonkman, JHG ;
van Heiningen, PNM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (04) :355-357
[23]   Absence of Pharmacokinetic Interaction Between Roflumilast and Digoxin in Healthy Adults [J].
Eckermann, Gabriel ;
Lahu, Gezim ;
Nassr, Nassr ;
Bethke, Thomas D. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (02) :251-257
[24]   Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin [J].
S. Snel ;
J. A. Jansen ;
P. C. Pedersen ;
J. H. G. Jonkman ;
P. N. M. van Heiningen .
European Journal of Clinical Pharmacology, 1998, 54 :355-357
[25]   Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers [J].
Vousden, M ;
Allen, A ;
Lewis, A ;
Ehren, N .
CHEMOTHERAPY, 1999, 45 (06) :485-490
[26]   Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin [J].
Sreeneeranj Kasichayanula ;
Ming Chang ;
Xiaoni Liu ;
Wen-Chyi Shyu ;
Steven C. Griffen ;
Frank P. LaCreta ;
David W. Boulton .
Advances in Therapy, 2012, 29 :163-177
[27]   Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters [J].
Emmanuelle Comets ;
Céline Verstuyft ;
Marc Lavielle ;
Patrice Jaillon ;
Laurent Becquemont ;
France Mentré .
European Journal of Clinical Pharmacology, 2007, 63 :437-449
[28]   Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin [J].
Kasichayanula, Sreeneeranj ;
Chang, Ming ;
Liu, Xiaoni ;
Shyu, Wen-Chyi ;
Griffen, Steven C. ;
LaCreta, Frank P. ;
Boulton, David W. .
ADVANCES IN THERAPY, 2012, 29 (02) :163-177
[29]   Modelling the influence of MDR1 polymorphism on digoxin pharmacokinetic parameters [J].
Comets, Emmanuelle ;
Verstuyft, Celine ;
Lavielle, Marc ;
Jaillon, Patrice ;
Becquemont, Laurent ;
Mentre, France .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) :437-449
[30]   Practical uses of individual pharmacokinetic parameters in drug development and clinical practice: Examples and simulations [J].
Bjornsson, TD .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1997, 22 (01) :1-14
12345